Healthcare provider profile · identity verified

Jeffrey A Cox, MD

Family Practice · NOBLESVILLE, IN · NPI 1801023171

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	909	259
Lisinopril	Lisinopril	426	117
Amlodipine Besylate	Amlodipine Besylate	390	117
Losartan Potassium	Losartan Potassium	377	109
Levothyroxine Sodium	Levothyroxine Sodium	354	91
Omeprazole	Omeprazole	270	85
Metformin Hcl	Metformin Hcl	218	64
Hydrochlorothiazide	Hydrochlorothiazide	216	59
Simvastatin	Simvastatin	211	58
Tamsulosin Hcl	Tamsulosin Hcl	203	66
Allopurinol	Allopurinol	169	41
Metoprolol Succinate	Metoprolol Succinate	166	50
Pantoprazole Sodium	Pantoprazole Sodium	147	38
Pravastatin Sodium	Pravastatin Sodium	146	38
Meloxicam	Meloxicam	141	39
Trazodone Hcl	Trazodone Hcl	141	41
Ezetimibe	Ezetimibe	129	37
Gabapentin	Gabapentin	124	45
Rosuvastatin Calcium	Rosuvastatin Calcium	123	40
Sertraline Hcl	Sertraline Hcl	120	33
Metformin Hcl Er	Metformin Hcl	116	34
Carvedilol	Carvedilol	112	31
Furosemide	Furosemide	111	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	111	26
Eliquis	Apixaban	105	27
Mounjaro	Tirzepatide	101	15
Duloxetine Hcl	Duloxetine Hcl	95	25
Clopidogrel	Clopidogrel Bisulfate	93	24
Famotidine	Famotidine	92	32
Albuterol Sulfate Hfa	Albuterol Sulfate	87	31
Metoprolol Tartrate	Metoprolol Tartrate	84	25
Zolpidem Tartrate	Zolpidem Tartrate	79	12
Escitalopram Oxalate	Escitalopram Oxalate	77	26
Montelukast Sodium	Montelukast Sodium	76	22
Tramadol Hcl	Tramadol Hcl	76	17
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	73	73
Shingrix	Varicella-Zoster Ge/As01b/Pf	73	61
Pregabalin	Pregabalin	70	17
Atenolol	Atenolol	69	19
Fluticasone Propionate	Fluticasone Propionate	68	22
Alendronate Sodium	Alendronate Sodium	65	29
Alprazolam	Alprazolam	64	17
Jardiance	Empagliflozin	63	15
Spironolactone	Spironolactone	61	22
Januvia	Sitagliptin Phosphate	59	16
Citalopram Hbr	Citalopram Hydrobromide	58	15
Donepezil Hcl	Donepezil Hcl	58	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	16
Hydroxyzine Hcl	Hydroxyzine Hcl	55	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	13
Ozempic	Semaglutide	52	suppressed
Benazepril Hcl	Benazepril Hcl	50	13
Synthroid	Levothyroxine Sodium	50	13
Paroxetine Hcl	Paroxetine Hcl	49	13
Glipizide	Glipizide	47	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	21
Glimepiride	Glimepiride	45	14
Celecoxib	Celecoxib	44	14
Finasteride	Finasteride	44	16
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	39	39
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Mirtazapine	Mirtazapine	38	11
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	22
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	12
Symbicort	Budesonide/Formoterol Fumarate	34	11
Bupropion Xl	Bupropion Hcl	32	12
Clonazepam	Clonazepam	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	11
Potassium Chloride	Potassium Chloride	32	14
Oxybutynin Chloride Er	Oxybutynin Chloride	30	11
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	12
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Prednisone	Prednisone	25	14
Clonidine Hcl	Clonidine Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Sildenafil Citrate	Sildenafil Citrate	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	11
Trulicity	Dulaglutide	20	suppressed
Valsartan	Valsartan	20	suppressed
Cephalexin	Cephalexin	19	15
Digoxin	Digoxin	19	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Dutasteride	Dutasteride	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	12
Ramipril	Ramipril	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Estradiol	Estradiol	16	suppressed
Linzess	Linaclotide	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Naproxen	Naproxen	13	suppressed
Savella	Milnacipran Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Nateglinide	Nateglinide	12	suppressed
Sodium Chloride	Sodium Chloride Irrig Solution	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Modafinil	Modafinil	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed
Topiramate	Topiramate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error